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Background: The pressor response to angiotensin II (AngII) is attenuated in adult females as compared to males
via an angiotensin type 2 receptor (AT2R)-dependent pathway. We hypothesized that adult female mice are
protected against AngII-induced hypertension via an enhanced AT2R-mediated pathway and that in reproductively
senescent females this pathway is no longer operative.
Methods: Mean arterial pressure was measured via telemetry in 4-month-old (adult) and 16-month-old (aged) and
aged ovariectomized (aged-OVX) wild-type and AT2R knockout (AT2R-KO) female mice during baseline and 14-day
infusion of vehicle (saline) or AngII (600 ng/kg/min s.c.). Real-time reverse transcription polymerase chain reaction
(RT-PCR) was used to determine renal gene expression of angiotensin receptors and angiotensin-converting enzyme
2 in response to 14-day treatment with vehicle or AngII.
Results: Basal mean arterial pressure was similar between the groups. The pressor response to AngII was
augmented in adult AT2R-KO compared to adult wild-type mice (29 ± 3 mmHg versus 10 ± 4 mmHg, respectively,
on day 14 as compared to basal mean arterial pressure, P = 0.002). In wild-type mice, pressor responsiveness to
AngII was augmented with age, such that the pressor response to AngII was similar between aged AT2R-KO and
wild-type female mice (31 ± 4 mmHg versus 34 ± 3 mmHg, respectively, on day 14, P = 0.9). There were no significant
differences in pressor responsiveness to AngII between aged and aged-OVX mice. Vehicle-treated aged wild-type mice
had a lower renal AT2R/AT1R balance as compared to adult counterparts. In response to AngII, the renal AT2R/AT1R
balance in aged wild-type females was greater than that observed in vehicle-treated aged wild-type females and adult
wild-type females, yet the protective effects of AT2R activation were not restored.
Conclusions: The protective role of the AT2R depressor pathway is lost with age in female mice. Therefore, targeting
deficits in AT2R expression and/or signaling may represent a novel anti-hypertensive approach in aged females.
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Women of reproductive age are protected from hyperten-
sion and cardiovascular disease (CVD) relative to postmen-
opausal women [1]. In the years following menopause,
arterial pressure increases, suggesting that the mechanisms
that regulate arterial pressure are altered with age. Sex hor-
mones are known to differentially regulate the renin angio-
tensin system (RAS), a key regulator of arterial pressure* Correspondence: kate.denton@monash.edu
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unless otherwise stated.[2]. Previous studies have demonstrated that estrogen en-
hances the RAS depressor pathways, which encompasses
the angiotensin-converting enzyme 2 (ACE2)/angiotensin
(1-7) (Ang(1-7))/MasR pathway and the angiotensin type 2
receptor (AT2R) [3-5]. Thus, the RAS depressor pathways
are thought to play a protective role in the setting of arter-
ial pressure in adult females of reproductive age [6,7].
Chronic angiotensin II (AngII)-induced hypertension
is attenuated in female as compared to male rodents
[4,8,9]. We have previously demonstrated that this sex
difference in pressor responsiveness to AngII is associ-
ated with higher renal AT2R expression in females asl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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increases the pressor responsiveness to AngII in adult
female mice to a similar extent to that observed in age-
matched male mice [4]. Collectively, these data indicate
that the AT2R plays a central role in the attenuated
pressor response to AngII-induced hypertension in fe-
males. In healthy adults, sexual dimorphism in the renal
vascular response to AngII has been identified, and it
has been suggested that the AT2R may be responsible
for these differences [10,11]. Given that AT2R expression
is estrogen dependent [3-5], it is plausible that repro-
ductive senescence may lead to lower AT2R expression
and, in turn, increased pressor responsiveness to AngII
in aged females.
In the present study, our aims were 2-fold: firstly, to
determine if renal AT2R expression is reduced in aged
reproductively senescent female mice and, secondly, to
determine if the attenuated pressor response to AngII
observed in adult female mice is still operative in aged re-
productively senescent female mice. We hypothesized that
adult female mice are protected against AngII-induced
hypertension via an enhanced AT2R-mediated pathway
and that with age and reproductive senescence this path-
way is no longer operative.
Methods
Experiments were conducted in accordance with the
Australian Code of Practice for the Care and Use of
Animals for Scientific Purposes and approved by the
Monash University School of Biomedical Sciences Animal
Ethics Committee. Female FVB/N wild-type (WT) and
AT2R knockout (AT2R-KO) mice, initially established by
Hein et al. [12], were obtained at 12 weeks of age (Monash
Animal Services). Animals were housed in an experimen-
tal room with temperature maintained at 24°C–26°C and
a 12-h light-dark cycle. Mice had ad libitum access to
normal salt diet (0.26% (w/w) NaCl; AIN93M, Specialty
Feeds, Australia) and water.
Animal model
Mice were divided into 12 groups: adult (4-month-old)
WT and AT2R-KO, aged (16-month-old) WT and AT2R-
KO, and aged ovariectomized (OVX) WT and aged-
OVX AT2R-KO receiving either vehicle or AngII for
14 days. OVX was performed at 14 months of age, as de-
scribed previously [13]. Vaginal smears confirmed that the
aged mice were in persistent estrus before commence-
ment of the study.
Experimental protocol
Mice were anesthetized (2.2%–2.6% isoflurane in 40% O2-
60% N2, Rhodia, Australia) for implantation of a radiote-
lemetry probe (TA11PA-C10, Data Sciences International,
MN, USA) into the left carotid artery, as describedpreviously [14]. Following a 10-day recovery period, basal
mean arterial pressure (MAP), heart rate (HR), and loco-
motor activity were measured by sampling for 10 s every
10 min using Dataquest ART data acquisition system
(Data Sciences International, MN, USA) for 3 days. There-
after, mice were briefly anesthetized (as described above),
for implantation of an osmotic pump into the midscapular
region (ALZET model 1002, Durect Corp., Cupertino,
CA) delivering AngII (600 ng/kg/min s.c.) or vehicle (0.9%
saline 0.25 μl/h s.c.). MAP, HR, and locomotor activity
were measured, as described above, over the 14-day treat-
ment period. At the conclusion of the experiment, animals
were anesthetized and killed by exsanguination via cardiac
puncture.
Renal AT1aR, AT1bR, AT2R, ACE2, and MasR gene
expression
RNA was extracted from kidneys following a 14-day in-
fusion of vehicle or AngII using the RNeasy Mini Kit
(Qiagen, Doncaster, Victoria, Australia). AT1aR, AT1bR,
AT2R, MasR, and ACE2 gene expressions were analyzed
by real-time quantitative reverse transcription polymer-
ase chain reaction (RT-PCR) Realplex software with
the Applied Biosystems 7900HT Fast RT-PCR system
(Applied Biosystems, Life Technologies, Australia).
Samples were run in triplicate using TaqMan gene expres-
sion assays (Applied Biosystems, Life Technologies, Australia)
and 18S rRNA as the internal housekeeping gene. Reac-
tions were set up on a 384-well PCR plate using an auto-
mated liquid handler (CAS-1200 liquid handler, Qiagen,
Australia) as per the manufacturer's instructions (Applied
Biosystems, Life Technologies, Australia). Calculations of
relative expression were carried out using the comparative
cycle of threshold fluorescence (2−ΔΔCT) method.
Statistical analysis
Data are presented as mean ± SEM. MAP, HR, and loco-
motor activity over the 14-day treatment period were
analyzed using repeated measures analysis of variance
(ANOVA) with the factors genotype (Pg) and time (Pt).
All other data were analyzed using a one-way ANOVA
followed by post hoc t-tests with Holm-Sidak correction
to reduce the risk of type 1 error associated with mul-
tiple comparisons. Comparisons were made to evaluate
the effect of age, genotype, or OVX. P ≤ 0.05 was consid-
ered statistically significant.
Results
Basal hemodynamics, locomotor activity, and body
weight
Basal values were pooled for the adult, aged, and aged-
OVX groups prior to vehicle or AngII infusion. Within
groups, there were no differences in basal hemodynamics,
locomotor activity or body weight between the animals
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24-h MAP was 93 ± 1 mmHg in adult WT and 94 ±
1 mmHg in adult AT2R-KO females (Table 1). Age did not
increase basal MAP (Table 1). Moreover, OVX had no ef-
fect on basal MAP in aged females (Table 1). Basal HR
was not different between the groups (Table 1). While
locomotor activity was similar between the genotypes,
there was a significant reduction in locomotor activity in
the aged-OVX WT versus aged WT females (Table 1, P =
0.03). Aged female mice were 4–6 g heavier than their
adult counterparts; however, this difference was not statis-
tically significant (Table 1). There was no difference in
body weight between aged and aged-OVX mice (Table 1).
Hemodynamic and locomotor activity responses to
treatment
There was no change in MAP in response to vehicle infu-
sion in any group (Figure 1A–C). The pressor response to
AngII was augmented in adult AT2R-KO versus adult WT
mice (Pg = 0.002, Figure 1D). In contrast, the pressor re-
sponse to AngII was similar between the aged WT and
AT2R-KO mice (Pg = 0.9, Figure 1E). The MAP response
to AngII over the 14-day treatment period was similar be-
tween the aged-OVX mice (Pg = 0.9, Figure 1F). Compari-
son of the HR and locomotor responses to treatment did
not detect any differences between the groups (data not
shown).
Pressor responsiveness on day 14 of AngII infusion was
analyzed further to compare responses between each
group. The increase in MAP, as compared to baseline, in
response to AngII infusion was 10 ± 4 mmHg in adult WT
females and 29 ± 3 mmHg in adult AT2R-KO females (P =
V 0.02, Figure 1G). Between WT females, pressor respon-
siveness to AngII was enhanced in aged WT female as
compared to adult WT female mice (P = 0.003, Figure 1G).
The increase in MAP in response to AngII observed
in the aged WT was comparable to that observed inTable 1 Basal hemodynamics, activity, and body weight







Adult WT (n = 13) 93 ± 1 570 ± 16 6 ± 1 22 ± 2
Aged WT (n = 11) 94 ± 1 555 ± 13 7 ± 1 28 ± 2
Aged-OVX WT (n = 12) 91 ± 1 548 ± 20 4 ± 1* 31 ± 3
Adult AT2R-KO (n = 12) 94 ± 1 565 ± 12 8 ± 1 23 ± 1
Aged AT2R-KO (n = 14) 93 ± 1 594 ± 11 7 ± 1 27 ± 2
Aged-OVX AT2R-KO (n = 12) 91 ± 1 588 ± 13 5 ± 1 27 ± 3
Data are presented as 24 h mean ± SEM. Data were analyzed using a one-way
ANOVA followed by selected post hoc t-tests with Holm-Sidak correction to
reduce the risk of type 1 error associated with multiple comparisons. MAP mean
arterial pressure, HR heart rate, bpm beats per minute, BW body weight, g grams.
*P < 0.05 versus aged WT.adult AT2R-KO and aged AT2R-KO female mice (34 ±
3 mmHg, 29 ± 3 mmHg, and 31 ± 4 mmHg, respectively,
Figure 1G). Moreover, there was no difference in pressor
responsiveness to AngII between the aged and aged-OVX
groups (Figure 1G).
Renal AT1aR, AT1bR, AT2R, MasR, and ACE2 gene
expression
Renal gene expression of the angiotensin receptors and
ACE2 were expressed relative to the vehicle-treated
adult WT mice. There were no differences in AT1bR,
ACE2, or MasR gene expression between the vehicle-
treated groups (Figure 2B,D,E). In vehicle-treated mice,
renal expression of the gene for the AT1aR was similar
between adult WT and AT2R-KO mice (Figure 2A). In
both genotypes, expression of the gene for the AT1aR
was 2.5-fold greater in aged versus adult mice (both P <
0.001, Figure 2). In contrast, expression of the gene for
the AT1aR was 50% lower in aged-OVX WT than aged
WT mice (P = 0.02, Figure 2A). Renal expression of the
gene for the AT2R was 52% lower in aged WT mice as
compared to adult WT mice (P = 0.03, Figure 2C).
Following a 14-day AngII treatment, renal AT1aR ex-
pression was ~3-fold higher in adult WT (P = 0.002) and
~2.5-fold higher in adult AT2R-KO (P = 0.02) female
mice than their vehicle-treated counterparts (Figure 2A).
AT2R expression was ~1-fold higher in AngII than
vehicle-treated aged WT mice (P = 0.003, Figure 2C). In
comparison, there were no differences in renal AT2R ex-
pression between vehicle and AngII treated adult WT
and aged-OVX WT mice (Figure 2C). In aged WT mice,
ACE2 gene expression was 2-fold higher in AngII than
vehicle-treated mice (P = 0.009, Figure 2D). In response
to AngII, ACE2 gene expression was ~45% lower in adult
and aged AT2R-KO mice as compared to WT counter-
parts (Figure 2D). In aged WT mice, ACE2 gene expres-
sion was 70% lower with OVX (P = 0.03, Figure 2D).
There were no significant differences in AT1bR or
MasR gene expression in response to AngII in any
group (Figure 2B,E).
Discussion
The main findings of the present study were that (i) the
AT2R attenuates pressor responsiveness to AngII in
adult female mice of reproductive age, in agreement with
our previous finding [4], (ii) with age, WT female mice
have an enhanced pressor response to AngII which is
similar to that observed in adult AT2R-KO mice, (iii)
pressor responsiveness to AngII is not increased further
with age in AT2R-KO female mice, and (iv) aging in WT
mice is associated with a shift in the depressor/pressor
balance of the renal RAS. Thus, the enhanced pressor
responsiveness to AngII observed with age in WT female
mice might be, at least in part, due to a shift in the
Figure 1 Mean arterial pressure response to angiotensin II
infusion. Mean arterial pressure (MAP) during baseline and 14-day
infusion of vehicle (0.9% saline, n = 4–8 per group; open symbols) in
(A) adult, (B) aged, and (C) aged-OVX or AngII (600 ng/kg/min, n= 6–8
per group; closed symbols) in (D) adult, (E) aged, and (F) aged-OVX
WT (black symbols) and AT2R-KO (grey symbols) female mice. (G) The
change in MAP from baseline at day 14 of AngII infusion in WT (black
symbols) and AT2R-KO (grey symbols) female mice. Data are presented
as 24 h mean ± SEM. Data in (A–F) were analyzed using repeated
measures ANOVA. The change in MAP on day 14 of AngII infusion was
analyzed using a one-way ANOVA followed by post hoc t-tests with
Holm-Sidak correction to reduce the risk of type 1 error associated with
multiple comparisons. *P < 0.05; **P < 0.01.
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cits in the downstream AT2R signaling pathways.
There was no difference in basal MAP between adult
WT and AT2R-KO female mice. Moreover, we did not
detect an increase in arterial pressure with age. This lat-
ter finding is consistent with our recent work which also
observed no significant difference in basal arterial pres-
sure between 4-month-old and 14-month-old female
mice [15]. Similar to the increase in arterial pressure
observed in postmenopausal women, which occurs in
the 10–15 years following menopause, we propose that a
time lag exists between reproductive senescence and the
increase in arterial pressure in aged female rodents. Re-
productively senescent spontaneously hypertensive rats
(SHR) have many of the hallmarks associated with the
increase in arterial pressure observed in postmenopausal
women, including increased plasma renin activity [16].
However, it has been demonstrated that although repro-
ductively senescent SHR cease regular estrus cycling at
10 months of age, the rise in arterial pressure to match
that measured in males is apparent by 18 months of age
[16,17]. Likewise, we have recently observed a similar
phenomenon in aged mice. Consistent with previously
published studies, which have demonstrated that mice
cease regular estrus cycling by 8–14 months of age
[18,19], in the present study and our earlier work, our
cohorts of aged female mice enter reproductive senes-
cence by 14 months of age [15]. However, the increase
in arterial pressure in reproductively senescent female
mice is apparent at 18 months of age, at which time the
sexual dimorphism in arterial pressure is lost in mice
(arterial pressure measured via radiotelemetry, unpub-
lished data).
In the present study, AT2R deficiency augmented pressor
responsiveness to AngII in adult female mice. This finding
is consistent with our earlier work, demonstrating that the
AT2R plays a protective role in the regulation of arterial
pressure in adult female rodents [4,8]. In these studies,
AT2R deficiency in adult mice and pharmacological block-
ade of the AT2R in adult rats augmented the pressor re-
sponse to AngII in females [4,8]. Moreover, we showed
that in response to a low dose of AngII, arterial pressure
was paradoxically decreased in adult female rats, an effect
that was inhibited by AT2R blockade [8]. Given that fe-
males have a greater AT2R to AT1R balance than males
[5,15,20,21], that the expression of depressor components
(ACE2/Ang(1-7)/MasR axis and the AT2R) of the RAS is
enhanced in females [7], and that AngII has ~15-fold
greater affinity for the AT2R than the AT1R [22], these
suggest that similar mechanisms underpin the depressor
response to a low-dose AngII and the attenuated pressor
response to a high-dose AngII infusion observed in female
rodents. Thus, in response to an AngII infusion in female
rodents, AngII will bind with greater affinity for the AT2R
Figure 2 Relative renal gene expression. The relative renal gene
expression of (A) AT1aR, (B) AT1bR, (C) AT2R, (D) ACE2, and (E) MasR in
WT (black bars) and AT2R-KO (grey bars) adult, aged, and aged-OVX
female mice following 14-day infusion of vehicle (0.9% saline s.c.) or
AngII (600 ng/kg/min s.c.). Data are presented as mean ± SEM and are
expressed relative to the adult WT vehicle-treated group. Data were
analyzed using a one-way ANOVA followed by 12 planned post hoc
t-tests with Holm-Sidak correction to reduce the risk of type 1 error
associated with multiple comparisons. *P < 0.05; **P < 0.01.
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AngIII and Ang(1-7), both of which activate the AT2R to
stimulate arterial pressure lowering effects [23-25]. Indeed,
in the present study we observed an increase in renal
ACE2 mRNA in AngII-treated adult and aged WT mice
treated.
While there is speculation in the literature that the
protective effects of estrogen on the regulation of arterial
pressure in females may be lost with age, this assump-
tion is based upon the evidence obtained from adult
OVX animals. For example, it has been demonstrated
that the pressor response to AngII in adult mice is aug-
mented by OVX and restored by estrogen replacement
[9,26]. Similarly, we have previously shown that in adult
rats the arterial depressor response to a low-dose AngII
infusion is abolished by OVX and restored by estrogen
replacement [13]. While these animal models are useful
for understanding the contribution of estrogen to the
normal regulation of arterial pressure in adult females,
they do not accurately represent the cardiovascular and
renal adaptations that accompany the aging process [27].
As a result, attempts to mimic menopause and loss of es-
trogen in adult OVX animals do not take into account the
effects of aging, including increased RAS activation, which
may influence angiotensin receptor levels independent of
alterations in circulating estrogen levels [16,28,29].
In the present study performed in aged females, we
clearly demonstrate an increase in the pressor respon-
siveness to AngII in aged WT female mice. Moreover,
the enhanced pressor response to AngII in aged WT
female mice was of a similar magnitude to that observed
in adult AT2R-KO female mice. In contrast, in AT2R-KO
female mice, there was no difference in the pressor re-
sponse to AngII with age. Together these findings sug-
gest that the increase in pressor responsiveness to AngII
is due to AT2R deficiency. At present, it is unclear if this
AT2R deficiency is due to an age-related reduction in
AT2R expression and/or activation. For example, in
vehicle-treated mice, the renal AT2R/AT1aR mRNA
expression balance was lower in aged than adult WT
female mice. Thus, normal aging decreases renal AT2R
mRNA expression in reproductively senescent female
mice. However, during pathological situations, such as
AngII-induced hypertension, there is a compensatory
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ductively senescent female mice. Despite the increase in
renal AT2R mRNA expression, the protective effects of
AT2R activation were not observed in reproductively
senescent female mice. This latter finding suggests that
the renal AT2R signaling pathways may be impaired with
age. Consistent with this hypothesis, renal ACE2 mRNA
expression was similar in AngII-treated adult and aged
WT mice. This may suggest that there is a similar level
of stimulation of the AT2R by ACE2-generated Ang(1-7)
in both adult and aged reproductively senescent female
mice during AngII-induced hypertension.
However, it is important to note that the current study
measured mRNA gene expression, which does not ne-
cessarily reflect protein expression or activity. Moreover,
mRNA gene expression was determined in transverse
kidney sections, which may mask subtle differences in
discrete regions of the kidney. Therefore, further investi-
gation of how the protective effects of renal AT2R acti-
vation are lost with age is warranted.
We have gained strong evidence that the AT2R elicits
sex-specific effects on arterial pressure and renal func-
tion in adult rodents. Within the kidney, the AT2R
maintains autoregulation of renal blood flow and glom-
erular filtration rate (GFR) at low renal perfusion pres-
sures in females and provides protection against the
vasoconstrictor effects of AngII [30]. The sensitivity of
the tubuloglomerular feedback mechanism, which is a
major regulator of renal vascular tone and thus GFR, to
AngII is reduced by the presence of the AT2R in female
but not male mice [4]. It is well documented that the
AT2R elicits its effects by activating the nitric oxide (NO)-
cyclic GMP (cGMP) pathway. In aging (8-month-old)
SHR, it has been demonstrated that estrogen-dependent
activation of the NO-cGMP pathway is reduced [31].
Given that estrogen increases AT2R expression, loss of
estrogen-dependent activation of the NO-cGMP pathway
may in part be due to a reduction in AT2R function.
In the present study, we were unable to reliably meas-
ure plasma estrogen levels as murine plasma estrogen
levels were below the detection limits of commercially
available estrogen assays. This is consistent with previ-
ously published studies, which have demonstrated that
commercial estrogen assays lack sensitivity and specifi-
city in female mice [32,33]. However, we did assess vagi-
nal cytology and confirmed that our cohort of aged mice
had entered reproductive senescence. Moreover, we in-
cluded an aged-OVX cohort in the present study to ac-
count for residual effects of ovarian-produced estrogen.
While we did not detect differences between aged and
aged-OVX female mice with respect to basal MAP or
pressor responsiveness to AngII, subtle differences were
observed in renal gene expression of RAS components,
indicating that an aged-OVX mouse is not equivalentto an aged (ovary-intact) mouse. Our conclusion is
also supported by previous studies that have observed
differential effects of adult-OVX, aged-OVX, and aging
alone, demonstrating that an OVX female, be it adult or
aged, is not equivalent to an aged ovary-intact female
[16,34]. Since the ovaries produce sex hormones other
than estrogen, including testosterone, progesterone, and
relaxin, alterations in the sex hormone milieu of aged fe-
males, as observed in reproductively senescent SHR [16],
may play a pivotal role in the loss of the estrogen-
dependent activation of NO-cGMP pathway. This may
be of particular importance given that recent evidence
indicates that heterodimer complexes formed between
the relaxin family peptide receptor 1 and the AT2R
activate the NO-cGMP pathway [35]. Certainly, it has
been demonstrated that the AT2R contributes to the
ability of relaxin to mediate renal anti-fibrotic effects
in vivo [35]. Hence, both estrogen and relaxin may be
required to elicit the arterial pressure lowering effects
of the AT2R.
To the best of our knowledge, the activation of the
protective RAS depressor pathways is yet to be mea-
sured in postmenopausal women. However, it is tempt-
ing to speculate that the balance of the RAS is shifted
postmenopause towards the pressor pathway. Certainly,
it is known that plasma renin activity is increased in
postmenopausal women compared to premenopausal
women [36,37]. Moreover, AT1R antagonism improves
vascular function in postmenopausal women who are
not receiving hormone replacement therapy [38]. Add-
itionally, treatment with candesartan unmasks a vaso-
dilator response to AngII in forearm resistance vessels
of elderly women (67 years), an effect that is partially
blocked by co-infusion of the AT2R antagonist PD123319
[39]. Consistent with a decrease in the depressor/
pressor balance of the RAS in aged females, increased
AT1R activation may potentiate other vasoconstrictive
mechanisms including endothelin-1 and reactive oxy-
gen species, which are thought to contribute to the age-
related increase in arterial pressure in postmenopausal
women [17].
Conclusions
Understanding the mechanisms contributing to the in-
crease in arterial pressure in females with aging is of the
utmost importance. Our study in mice demonstrates
that pressor responsiveness to AngII is increased follow-
ing reproductive senescence, and moreover, that this is
associated with loss of the protective depressor RAS
pathways. These findings provide novel insight into age-
related changes in the RAS and imply that different
therapeutic strategies may be required to effectively treat
hypertension in premenopausal and postmenopausal
women.
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